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ABSTRACT. Objective: This study compares the likelihood of suicidal 
ideation and suicide attempt across stages of nonmedical prescription 
opioid use and by presence of prescription opioid disorders (dependence 
and/or abuse) among adult respondents. Method: In the 2009 National 
Survey on Drug Use and Health, 37,933 adult respondents were asked if 
they had thought about suicide or had attempted suicide in the past year. 
The likelihood of ideation and attempt were compared across the follow-
ing four categories: (a) those who never used prescription opioids, (b) 
former users, (c) persistent users, and (d) recent-onset users. Weighted 
multinomial logistic regressions were used to examine if these stages 
and presence of Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, criteria for prescription opioid disorders were associ-
ated with suicidal ideation and suicide attempt. Results: Five percent 
of respondents (n = 2,021) reported suicidal ideation; of these, 15% (n 
= 310) reported attempt. Former and persistent nonmedical prescription 
opioid users had greater odds of suicidal ideation than those who never 
used these medications nonmedically. The stages of prescription opioid 
use were not associated with suicide attempt. Presence of prescription 
opioid disorders among past-year prescription opioid users was as-
sociated with suicidal ideation but not suicide attempt. Conclusions: 
The risk for suicidal ideation was greater in those who no longer used 
prescription opioids, in persistent users, and among nonmedical users 
who had a prescription opioid disorder compared with users without the 
disorder. The results suggest a need to continue monitoring for suicide 
risk even among those who have stopped using prescription opioids. (J. 
Stud. Alcohol Drugs, 73, 178–184, 2012)
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THE INCREASE OF NONMEDICAL PRESCRIPTION opioid use in the United States has become a public 
health concern (Compton and Volkow, 2006; Zacny et al., 
2003). A recent Drug Abuse Warning Network report found 
a statistically signifi cant increase in number of emergency 
department visits involving prescription opioids (Substance 
Abuse and Mental Health Services Administration 
[SAMHSA], 2010b). Given the extent of the problem, many 
studies have characterized individuals who use nonmedical 
prescription opioids to better understand the population 
of nonmedical prescription opioid users (Becker et al., 
2008; Brands et al., 2004; Huang et al., 2006; Martins et 
al., 2009b; Sigmon, 2006). A strong association between 
psychiatric disorders and nonmedical prescription opioid 
use (Becker et al., 2008; Cicero et al., 2008) and disorders 
(Grella et al., 2009; Huang et al., 2006; Martins et al., 
2009a) suggests the importance of addressing mental health 
problems among this population. A high risk for mental 
disorders motivates examination of risk for suicidal behavior 
(ideation and/or attempt), as mental disorders are among 
the strongest risk factors for suicidal ideation (Goldney et 
al., 2000).
 However, little research has been conducted on this 
topic among the population of nonmedical prescription 
opioid users. Generally, drug users are at higher risk for 
suicide-related risks such as ideation, attempt, and death 
than those who do not misuse drugs (Borges et al., 2000; 
Wilcox et al., 2004), and nonmedical prescription opioid 
users are no exception (Borges et al., 2000). Most studies 
on suicide-related risks among drug users have focused on 
users of heroin (Darke and Ross, 2002) and cocaine (Garlow 
et al., 2003; Roy, 2001). At least one study indicated that 
a greater proportion of individuals who used nonmedical 
prescription opioids had a history of suicide attempt than 
those who used heroin alone among those in methadone-
maintenance treatments (Brands et al., 2004). Additionally, 
individuals who use prescription opioids nonmedically may 
indicate underlying chronic pain. A number of studies, not 
specifi c to nonmedical prescription opioid users, have found 
that individuals with chronic pain are at an increased risk 
for suicidal ideation and suicide attempt (Tang and Crane, 
2006).
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 Many studies that examine drug use in general and 
suicide-related risks have simply compared those who 
have ever used a specifi ed drug with those who have never 
used that drug. However, variations exist even within 
those who use prescription opioids nonmedically, ranging 
from experimental or occasional use to chronic use. 
One study that differentiated persistent and recent-onset 
users of nonmedical prescription opioids found stronger 
associations of depressive symptoms with recent-onset use 
compared with nonuse, and with persistent use compared 
with former use (Dowling et al., 2006). These fi ndings 
suggest that suicide-related risks may vary depending 
on the stage of nonmedical prescription opioid use as 
well. Data from the U.S. National Comorbidity Survey 
(1990–1992) have shown that current use of nonmedical 
prescription opioids increased risk for suicide attempt but 
former use did not (Borges et al., 2000). However, that 
study did not differentiate current users into persistent and 
recent-onset users.
 The present study used recent data from another 
national epidemiological sample, the National Survey 
on Drug Use and Health (NSDUH), to examine further 
the likelihood of suicidal ideation and suicide attempt 
and its relationship with nonmedical prescription opioid 
use among adult respondents. We compared the odds of 
suicidal ideation and suicide attempt across four groups 
of individuals based on their nonmedical prescription 
opioid use: (a) those who never used prescription opioids 
nonmedically, (b) former users, (c) persistent users, and 
(d) recent-onset users. We also examined if nonmedical 
prescription drug use disorder increases the odds for 
suicidal ideation and suicide attempt.
Method
Data sources
 Data for this study were drawn from the 2009 NSDUH 
public use f iles (SAMHSA, 2010c). The NSDUH is 
sponsored by SAMHSA and is designed to provide estimates 
of the prevalence of nonmedical use of legal and illegal 
drugs in the United States household population ages 
12 years and older. Surveys have been conducted on a 
regular basis since 1971. Interviews were conducted using 
a computer-assisted questionnaire and audio computer-
assisted self-interviewing to increase the validity of self-
reports of illicit drug use and other sensitive behaviors 
by providing confi dential means for the interviewees to 
respond to these questions (SAMHSA, 2010a). Respondents 
were offered a $30 incentive payment for participation 
in the survey. Overall weighted response rate for 2009 
was 75.7%. Detailed information about the sampling and 
survey methodology in the NSDUH are found elsewhere 
(SAMHSA, 2010a). In this report, we focused on 37,933 
respondents 18 years and older from 2009 NSDUH public 
use data (SAMHSA, 2010a).
Measurement
 Suicidal ideation and suicide attempt. Suicidal ideation 
was assessed by asking whether respondents seriously 
thought about trying to kill themselves in the past 12 
months. Suicide attempt was similarly assessed by asking if 
the respondent tried to kill himself or herself in the past 12 
months.
 Nonmedical prescription opioid use. Respondents were 
asked whether they had ever used a pain reliever that 
was not prescribed or if they had used a pain reliever for 
the experience or feeling it caused. If the response was 
affi rmative, respondents were presented with pictures and 
names of different types of prescription opioids and asked 
if they had used them nonmedically (SAMHSA, 2010a). 
Past-year nonmedical prescription opioid use was based 
on the response to the following question: “How long has 
it been since you last used any prescription pain reliever 
that was not prescribed for you or that you took only 
for the experience or feeling it caused?” If the response 
indicated nonmedical use during the preceding 12 months, 
the respondent was classifi ed as a nonmedical prescription 
opioid user within the past year. The respondents were also 
asked the year in which they started using prescription 
opioids nonmedically. Using these measures, we further 
classifi ed respondents into those who had formerly used 
nonmedical prescription opioids, those who persistently 
used, and recent-onset users, as defi ned in a previous study 
(Dowling et al., 2006). Former users were defi ned as those 
who had initiated nonmedical prescription opioid use 
more than 2 years before the assessment and had not used 
nonmedical prescription opioids in the past year. Similarly, 
persistent users were those who had initiated use more than 
2 years before the assessment and have also continued to use 
in the past year. Recent-onset users consisted of respondents 
who had initiated use within 2 years of the assessment.
 Prescription opioid disorder because of nonmedical use. 
In the NSDUH, 10 questions were used to measure the seven 
Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV; American Psychiatric Association, 
1994), symptoms of prescription opioid dependence 
experienced during the 12 months before the interview 
(SAMHSA, 2010a). Symptoms of past-year prescription 
opioid dependence were self-reported, and respondents were 
classifi ed as dependent if they met the DSM-IV criteria for 
prescription opioid dependence (three of seven symptoms). 
The NSDUH includes fi ve questions that examine the four 
prescription opioid abuse symptoms as defi ned by DSM-IV. 
Prescription opioid disorder was defi ned as meeting the 
criteria for prescription opioid abuse and/or dependence in 
the past year.
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Major depressive episode
 Presence of major depressive episode (MDE) was 
assessed using several questions that asked about clinical 
features of depression. All adult respondents were asked 
nine questions regarding the symptoms of MDE that follow 
the DMS-IV criteria (American Psychiatric Association, 
1994) and were derived from the National Comorbidity 
Survey–Replication (Harvard School of Medicine, 2005). 
A respondent met criteria for lifetime MDE if respondents 
reported fi ve or more of the symptoms nearly every day in 
the same 2-week period during their worst or most recent 
period. At least one of these fi ve symptoms needed to 
include depressed mood or loss of interest or pleasure in 
daily activities (apathy) to meet MDE criteria. If some of 
these symptoms also occurred within the last 12 months, 
these respondents were further classifi ed as those with past-
year MDE. In the survey, respondents were considered as 
having an MDE even if the episode was related to substance 
use, grief, or physical comorbidity (SAMHSA, 2010a).
 Other individual characteristics. All respondents provided 
information about their drug experiences and other personal 
data (e.g., demographic data). The demographic variables 
selected for this study were gender, age of respondent at 
time of interview, race/ethnicity (non-Hispanic Whites, non-
Hispanic Blacks, Hispanics, and other [Native Americans, 
Asians, Hawaiians, Pacifi c Islanders, and non-Hispanics 
who reported more than one race were combined because of 
small sample size]), education (at least high school), marital 
status (married, single, and no longer married [widowed, 
divorced, or separated]), and employment status (employed 
if full time or part time). We also examined lifetime use 
of other drugs and past-year presence of other drug use 
disorders (including cocaine, heroin, inhalants, marijuana, 
and other nonmedical prescription drug use [stimulants, 
sedatives, tranquilizers]). The lifetime use of other drugs was 
measured by asking the respondents if they had ever used 
each of these drugs. Individuals who met DSM-IV criteria 
for abuse and/or dependence in the past year for any of these 
drugs were considered to have drug use disorders. For the 
purpose of analysis, lifetime use and disorders were counted 
as occurring for no drugs, one drug, or two or more drugs.
Statistical analyses
 Initially, a Pearson test statistic, corrected for the survey 
design, was used to compare suicidal ideation and suicide 
attempt across demographic, nonmedical prescription opioid 
use and disorders and other drug use characteristics. This 
calculates the F statistic, but its p value can be interpreted 
similarly to the p value of the chi-square statistics in 
nonsurvey data (Koch et al., 1975; Rao and Scott, 1984). 
A set of logistic regression models estimated the odds 
of suicidal ideation and for attempt (among those with 
ideation) for former users, persistent users, and recent-onset 
users of nonmedical prescription opioids, as compared with 
never users. The second set of models focused on past-year 
nonmedical prescription opioid users to estimate the relative 
odds of ideation and attempt (among those with ideation) by 
presence of past-year prescription opioid disorders. These 
two sets of models were conducted in a stepwise manner (a) 
adjusting for demographics, (b) adjusting for demographics 
and lifetime use of other drugs, and (c) adjusting for 
demographics, lifetime use of other drugs, and MDE in the 
past year. The models that examined the association between 
past-year prescription opioid disorders were adjusted for 
presence of past-year other drug use disorders instead of 
lifetime use of other drugs. Because prior research suggested 
gender differences in nonmedical prescription opioid use 
(Cicero et al., 2008; Green et al., 2009; Tetrault et al., 2007), 
an interaction term was added to each model to examine 
if the relationships varied by gender. All analyses were 
conducted using a revised sampling weight that adjusted for 
complex sampling design as recommended by NSDUH and 
were conducted with Stata version 10 (StataCorp LP, College 
Station, TX).
Results
 Of the 37,933 adult respondents, 15% (n = 7,468) 
reported nonmedical use of prescription opioids during their 
lifetime. Nine percent (n = 3,769) of the adult respondents 
were former users of nonmedical prescription opioids who 
reported use more than 2 years ago, 4% (n = 2,031) were 
persistent users, and 2% (n = 1,668) were recent-onset 
users. Five percent (n = 3,080) used nonmedical prescription 
opioids in the past year (includes both recent-onset and 
persistent users), of whom 15% (n = 487) also met DSM-
IV criteria for prescription opioid disorders (abuse and/or 
dependence) (Table 1).
 Table 1 shows the distribution of stage of nonmedical 
prescription opioid use, presence of prescription opioid 
disorders, other drug use and other drug use disorders, and 
demographic characteristics, as well as prevalence of suicidal 
ideation and suicide attempt (among ideators) across these 
characteristics. Overall, 2,021 (5%) of the respondents 
reported having suicidal ideation in the past year; 310 of 
those with ideation (15%) also reported suicide attempt in 
the past year.
 Approximately 7% of the former users (n = 310), 11% 
of the persistent users (n = 287), and 9% of the recent-onset 
users (n = 178) reported ideation, whereas 3% of never 
users reported ideation, F(2.58, 155.01) = 91.91, p < .001. 
A greater proportion of persistent (17%) and recent-onset 
(19%) users with ideation also reported attempt as compared 
with former and never users (7% and 11%, respectively), 
F(2.64, 158.11) = 4.04, p < .01. Twenty-three percent of 
nonmedical users with past-year prescription opioid disorder 
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TABLE 1. Prevalence of suicidal ideation and suicide attempt (among ideators) by nonmedical prescription opioid use, disorder, and demographic character-
istics, NSDUH 2009a,b,c
 Among ideators
  Reported    Reported
  ideation   With attempt
 Overall (n = 2,021;   ideation (n = 310;
 (n = 37,933) 5%) Test  (n = 2,021) 15%) Test
Variable n n (%) statistic p n n (%) statistic p
Stages of nonmedical
prescription opioid use
 Never users 30,465 1,246.(3)    1,246 163.(11)
 Former users 3,769 310.(7) F(2.58, 155.01)  310 43.(7) F(2.64, 158.11)
 Persistent users 2,031 287.(11)  = 91.91 <.001 287 63.(17)  = 4.04 .01
 Recent-onset users 1,668 178.(9)    178 41.(19)
Gender
 Male 17,696 837.(4) F(1, 60) = 0.23 .34 837 118.(12) F(1, 60) .63
 Female 20,237 1,184.(4)    1,184 192.(11)  = 0.23
Age, in years
 18–25 18,924 1,216.(6) F(1.59, 95.69)  1,216 216.(17) F(1.82, 108.93)
 26–34 5,613 271.(4)  = 33.98 <.001 271 33.(9)  = 5.78 .005
 35 and older 13,396 534.(3)    534 61.(10)
Marital status
 Married 13,487 431.(2) F(1.86, 111.39)  431 49.(9) F(1.99, 119.49)
 No longer married 4,267 283.(5)  = 58.62 <.001 283 42.(10)  = 2.26 .11
 Never married 20,179 1,307.(6)    1,307 219.(14)
Education
 Less than high school 6,372 423.(5) F(1, 60) .006 423 93.(15) F(1,60) .10
 High school and above 31,561 1,598.(4)  = 8.08  1,598 217.(11)  = 2.86
Race
 Non-Hispanic White 24,078 1,294.(4)    1,294 175.(10)
 Non-Hispanic Black 4,651 231.(3) F(2.87, 172.25) .13 231 47.(18) F(2.86, 171.33) .14
 Hispanic 5,942 278.(3)  = 1.90  278 48.(10)  = 1.89
 Other 3,262 218.(4)    218 40.(15)
Unemployment
 No 25,323 1,176.(3) F(1,60) <.001 1,176 143.(8) F(1,60) .003
 Yes 12,610 845.(4)  = 12.44  845 167.(16)  = 14.55
Other lifetime drug use
 None 17,792 536.(2) F(1.79, 107.17)  536 61.(12) F(1.93, 115.70)
 One 9,531 497.(3)  = 92.94 <.001 497 83.(14)  = 2.36 .10
 Two or more 10,610 988.(7)    988 166.(10)
Other drug use disorder
 None 36,277 1,734.(3) F(1.92, 115.23)  1,734 245.(11) F(1.93, 115.70)
 One 1,386 206.(14)  = 160.94 <.001 206 39.(16)  = 2.36 .11
 Two or more 270 81.(32)    81 26.(20)
Past-year major
depressive episode
 No 34,709 1,065.(2) F(1, 60)  1,065 126.(10) F(1, 60) .08
 Yes  3,011 935.(26)  = 1508.06 <.001 935 178.(14)  = 3.12
Prescription opioid
disorders among past-year
users (n = 3,080)
 No 2,593 291.(9) F(1, 60) <.001 291 59 (17) F(1, 60) .94
 Yes 487 121.(23)  = 36.42  121 33 (17)  = 0.005
Notes: Bold indicates statistical signifi cance; NSDUH = National Survey on Drug Use and Health. aAll percentages are weighted; bincludes Native Americans, 
Asians, Hawaiians, Pacifi c Islanders, and non-Hispanics who reported more than one race; cother drugs include cocaine, heroin, inhalants, marijuana, and other 
nonmedical prescription drug use (stimulants, sedatives, tranquilizers).
reported ideation in the past year; in contrast, only 9% of 
nonmedical prescription opioid users who did not meet 
criteria for dependence and/or abuse reported ideation, 
F(1, 60) = 36.42, p < .001. The occurrence of attempt 
did not differ by presence of prescription opioid disorders 
among those with ideation. Prevalence of suicidal ideation 
differed signifi cantly across most demographic and drug 
use characteristics except for gender and race. Prevalence 
of suicide attempt among those who reported ideation 
did not differ for most characteristics except for age and 
unemployment.
 Table 2 compares the odds of suicidal ideation and 
suicide attempt across nonmedical prescription opioid former 
users, persistent users, and recent-onset users relative to 
never users. Without any adjustments for demographic and 
drug use characteristics, former, persistent, and recent-onset 
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users were each more likely to report ideation compared with 
never users of nonmedical prescription opioids (unadjusted 
odds ratio [uOR] for former users = 2.68, 95% CI [2.16, 
3.34]; uOR for persistent users = 4.27, 95% CI [3.32, 
5.49]; uOR for recent-onset users = 3.11, 95% CI [2.40, 
4.03]). The associations were still present after adjusting 
for demographic characteristics, although these ORs were 
reduced to 2.54 (95% CI [2.05, 3.16]), 3.51 (95% CI [2.70, 
4.58]), and 2.21 (95% CI [1.71, 2.86]) for former, persistent, 
and recent-onset users, respectively. With the addition 
of other lifetime drug use in the model, the associations 
persisted, although the magnitude diminished considerably, 
with ORs ranging from 1.51 for recent-onset users to 2.16 
for persistent users. Once the model further adjusted for 
presence of past-year MDE, only former and persistent 
users had increased odds of suicidal ideation (adjusted OR 
[aOR] for former users = 1.42, 95% CI [1.11, 1.81]; aOR for 
persistent users = 1.52, 95% CI [1.10, 2.10]) as compared 
with never users. Among ideators, persistent users also had 
increased odds for attempt as compared with never users 
(uOR = 1.69, 95% CI [1.01, 2.83]). This association was no 
longer signifi cant after adjusting for demographics.
 The association between suicidal ideation, attempt, and 
prescription opioid disorders is shown on the bottom row of 
Table 2. Among individuals who used prescription opioids 
nonmedically in the past year, those who also met criteria 
for prescription opioid disorders had more than threefold 
increased odds for reporting ideation compared with those 
without prescription opioid disorders (uOR = 3.10, 95% 
CI [2.10, 4.59]). The ORs reduced slightly after adjusting 
for demographics characteristics (aOR = 3.02, 95% CI 
[2.02, 4.53]). The magnitude of the OR further diminished 
but the association was still present when other drug use 
disorders and past-year MDE were included in the model 
(aOR = 1.88, 95% CI [1.13, 3.12]). Presence of prescription 
opioid disorders was not associated with suicide attempt 
among those who reported ideation and use prescription 
opioids nonmedically in the past year. No signifi cant gender 
differences were noted in any association.
Discussion
 Using data from a U.S. household sample of adults 18 
years and older, we found that former and persistent users 
but not recent-onset users of nonmedical prescription opioids 
were more likely to report suicidal ideation as compared 
with those who never used these drugs. These associations 
were accounted for in part by demographics, other lifetime 
drug use, and past-year MDE; however, the associations 
remained even after these adjustments. The odds of reporting 
ideation did not differ across these stages of nonmedical 
prescription opioid use. Among past-year nonmedical 
prescription opioid users, individuals who met criteria for 
prescription opioid disorders were also more likely to report 
suicidal ideation but were no more likely to report suicide 
attempt.
 Previous studies have noted that individuals who use 
illegal drugs have increased risk for suicidal behavior 
TABLE 2. Stages of nonmedical prescription opioid use and presence of prescription opioid disorders on odds for ideation and attempt among adult respon-
dents, NSDUH 2009 (n = 37,933)
 Ideation Attempt among ideators
    aOR    aOR
   aOR [95% CI]   aOR [95% CI]
  aOR [95% CI] demographics  aOR [95% CI] demographics
 uOR [95% CI] demographics + drug use uOR [95% CI] demographics + drug use
Variable [95% CI] demographics1 + drug use2,3 + MDE4 [95% CI] demographics1 + drug use2,3 + MDE4
Stages of nonmedical
prescription opioid
use (ref.: never users)
 Former users 2.68 2.54 1.62 1.42 0.60 0.68 0.79 0.78
   [2.16, 3.34]*** [2.05, 3.16]*** [1.29, 2.03]*** [1.11, 1.81]** [0.32, 1.15] [0.35, 1.32] [0.42, 1.50] [0.41, 1.49]
 Persistent users 4.27 3.51 2.16 1.52 1.69 1.53 1.84 1.73
   [3.32, 5.49]*** [2.70, 4.58]*** [1.64, 2.84]*** [1.10, 2.10]* [1.01, 2.83]* [0.92,2.56] [1.07,3.16] [0.97,3.09]
 Recent-onset users 3.11 2.21 1.51 1.27 1.84 1.29 1.46 1.52
   [2.40, 4.03]*** [1.71, 2.86]*** [1.17, 1.95]** [0.94, 1.73] [1.00, 3.45] [0.67, 2.50] [0.74, 2.88] [0.78, 2.96]
Abuse and/or 3.10 3.02 2.38 1.88 0.97 0.98 0.89 0.87
 dependence among [2.10, 4.59]*** [2.02, 4.53]*** [1.52, 3.71]*** [1.13, 3.12]* [0.42, 2.26] [0.43, 2.23] [0.37, 2.17] [0.37, 2.04]
  past-year users
Notes: Bold indicates statistical signifi cance. NSDUH = National Survey on Drug Use and Health; uOR = unadjusted odds ratio; aOR = adjusted odds ratio; 
MDE = major depressive episode. 1aOR for stages of nonmedical prescription opioid use: odds ratio adjusted for gender, age, education, race, marital status, 
unemployment; 2aOR for stages of nonmedical prescription opioid use: odds ratio adjusted for demographics described above and other lifetime drug use (co-
caine, heroin, inhalants, marijuana, and other nonmedical prescription drugs use [stimulants, sedatives, tranquilizers]); 3aOR for prescription opioid disorder: 
odds ratio adjusted for gender, age, education, race, marital status, unemployment, other past-year drug use disorder (cocaine, heroin, inhalants, marijuana, 
and other nonmedical prescription drugs use [stimulants, sedatives, tranquilizers]); 4aOR adjusted for demographics described above, other lifetime drug use 
(for stages of nonmedical prescription opioid use), or other past-year drug use (for prescription opioid disorder) and past-year MDE.
*p < .05; **p < .01; ***p < .001.
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(Borges et al., 2000; Darke and Ross, 2002). This study 
further found that ideation is not similarly associated with 
different stages of nonmedical prescription opioid use. 
Although all stages of nonmedical prescription opioid 
use were strongly associated with suicidal ideation, 
the associations with recent-onset users was no longer 
significant after accounting for past-year MDE. The 
presence of MDE is a strong risk factor for suicidal ideation 
(Goldney et al., 2000), and recent studies suggest that 
past-year MDE can also be a risk factor for nonmedical 
prescription opioid use, possibly through self-medication 
(Khantzian, 1985). At least one study noted that presence 
of mood and anxiety disorders increased the risk of incident 
nonmedical prescription drug use (Martins et al., 2011). 
As such, MDE could have been a strong shared factor that 
largely explained the association between recent nonmedical 
prescription opioid use and suicidal ideation. However, it is 
still concerning to fi nd that suicidal ideation may still persist 
even when individuals were no longer using prescription 
opioids nonmedically, which suggests a need for continued 
monitoring of suicide risk for these individuals. Given that 
the association remained even after adjusting for MDE, there 
may be other factors that potentially explain the association 
between former and persistent nonmedical prescription 
opioid users and suicidal ideation.
 Several studies have suggested that drug users, at least 
with respect to heroin users, have greater risk for suicidal 
behavior because these individuals may have shared 
vulnerability, such as family and social dysfunctions (Darke 
and Ross, 2002; Maloney et al., 2007). Such unobserved 
factors may have contributed to the association between 
prescription opioid disorders and ideation in our study as 
well. Individuals who are receiving prescription opioids 
may also have increased risk for chronic pain, which has 
been associated with suicidal behavior in earlier research 
(Cheatle, 2011) and suicide (Ilgen et al., 2010) independent 
of psychiatric comorbidities.
 It is also possible that former nonmedical prescription 
opioid use increased the risk for suicidal ideation. 
Neurobiological changes may increase suicidal behavior 
(Bondy and Zill, 2009), although the extent to which chronic 
use of prescription opioids contributes to these changes has 
not been specifi cally examined. A more recent longitudinal 
study suggested there is a strong association between 
mood disorder and nonmedical use of prescription opioids, 
whereby nonmedical prescription opioids may increase the 
risk for mood/anxiety disorder (Schepis and Hakes, 2011).
 Severity and dependence of drug use, not specifi c to 
prescription opioids, has also been associated with increased 
risk for suicidal ideation in previous studies (Borges et 
al., 2000; Cottler et al., 2005). The current study is one 
of the few to support that severe prescription opioid use, 
as indicated by presence of dependence and/or abuse, is 
also associated with increased odds for suicidal ideation. 
Furthermore, our fi ndings are generally consistent with 
previous fi ndings that suggest that those who use drugs 
illegally and meet the criteria for drug use disorders are at 
increased risk for suicidal ideation but not attempt among 
those who report ideation (Borges et al., 2008).
 Several limitations should caution the interpretation of 
the fi ndings. Although large epidemiological data sets are 
useful for examining risks for suicidal ideation and suicide 
attempt across nonmedical prescription opioid users at 
different stages of use and prescription opioid disorders, 
we cannot infer causal relationship because of the cross-
sectional design of this study. The results from NSDUH also 
may not be generalizable to nonhousehold populations, such 
as incarcerated individuals. The suicide attempt question 
did not delve into details about severity of attempt. The 
survey does not ask about chronic pain, which could be 
an important issue. Moreover, NSDUH data do not ask 
respondents about their reasons for nonmedical prescription 
opioid use (e.g., to relieve psychiatric symptoms or to get 
high). The surveys were based on self-report, but the use of 
a computerized reporting system minimizes the impact of 
social desirability bias on reporting (Turner et al., 1998).
 However, the study is one of the few to compare the 
likelihood of suicidal ideation across those with different 
stages of nonmedical prescription opioid use and by presence 
of prescription opioid disorders because of nonmedical 
use. The results reinforce that those with more advanced 
stages of nonmedical prescription opioid use, as refl ected 
by presence of dependence/abuse and persistent use, are a 
high-risk group for suicidal ideation among those who are 
using prescription opioids nonmedically. The results further 
suggest that suicidal ideation may persist even among 
those who no longer use nonmedical prescription opioids. 
The focus on mental health and monitoring of suicidal 
ideation should expand beyond current users of nonmedical 
prescription opioids to former users of nonmedical 
prescription opioids.
Acknowledgment
 The data reported herein come from the public use fi les of the NSDUH 
2009, collected and prepared by Research Triangle Institute under the aus-
pices of SAMHSA. This work was performed while S. Janet Kuramoto was 
a student at The Johns Hopkins Bloomberg School of Public Health.
References
American Psychiatric Association. (1994). Diagnostic and statistical manual 
of mental disorders (4th ed.). Washington, DC: Author.
Becker, W. C., Sullivan, L. E., Tetrault, J. M., Desai, R. A., & Fiellin, D. A. 
(2008). Non-medical use, abuse and dependence on prescription opioids 
among U.S. adults: Psychiatric, medical and substance use correlates. 
Drug and Alcohol Dependence, 94, 38–47.
Bondy, B., & Zill, P. (2009). Neurobiology of suicide. In D. B. Wildenauer 
(Ed.), Molecular biology of neuropsychiatric disorders (Vol. 23, pp. 
205–227). Berlin, Germany: Springer-Verlag.
184 JOURNAL OF STUDIES ON ALCOHOL AND DRUGS / MARCH 2012
Borges, G., Angst, J., Nock, M. K., Ruscio, A. M., & Kessler, R. C. (2008). 
Risk factors for the incidence and persistence of suicide-related out-
comes: A 10-year follow-up study using the National Comorbidity 
Surveys. Journal of Affective Disorders, 105, 25–33.
Borges, G., Walters, E. E., & Kessler, R. C. (2000). Associations of sub-
stance use, abuse, and dependence with subsequent suicidal behavior. 
American Journal of Epidemiology, 151, 781–789.
Brands, B., Blake, J., Sproule, B. A., Gourlay, D., & Busto, U. E. (2004). 
Prescription opioid abuse in patients presenting for methadone mainte-
nance treatment. Drug and Alcohol Dependence, 73, 199–207.
Cheatle, M. D. (2011). Depression, chronic pain, and suicide by overdose: 
On the edge. Pain Medicine, 12, Supplement s2, S43–S48.
Cicero, T. J., Lynskey, M., Todorov, A. A., Inciardi, J. A., & Surratt, H. L. 
(2008). Co-morbid pain and psychopathology in males and females 
admitted to treatment for opioid analgesic abuse. Pain, 139, 127–135.
Compton, W. M., & Volkow, N. D. (2006). Major increases in opioid an-
algesic abuse in the United States: Concerns and strategies. Drug and 
Alcohol Dependence, 81, 103–107.
Cottler, L. B., Campbell, W., Krishna, V. A., Cunningham-Williams, R. 
M., & Abdallah, A. B. (2005). Predictors of high rates of suicidal 
ideation among drug users. Journal of Nervous and Mental Disease, 
193, 431–437.
Darke, S., & Ross, J. (2002). Suicide among heroin users: rates, risk factors 
and methods. Addiction, 97, 1383–1394.
Dowling, K., Storr, C. L., & Chilcoat, H. D. (2006). Potential infl uences on 
initiation and persistence of extramedical prescription pain reliever use 
in the US population. Clinical Journal of Pain, 22, 776–783.
Garlow, S. J., Purselle, D., & D’Orio, B. (2003). Cocaine use disorders and 
suicidal ideation. Drug and Alcohol Dependence, 70, 101–104.
Goldney, R. D., Wilson, D., Dal Grande, E., Fisher, L. J., & McFarlane, A. 
C. (2000). Suicidal ideation in a random community sample: Attribut-
able risk due to depression and psychosocial and traumatic events. 
Australian and New Zealand Journal of Psychiatry, 34, 98–106.
Green, T. C., Grimes Serrano, J. M., Licari, A., Budman, S. H., & Butler, 
S. F. (2009). Women who abuse prescription opioids: Findings from 
the Addiction Severity Index-Multimedia Version Connect prescription 
opioid database. Drug and Alcohol Dependence, 103, 65–73.
Grella, C. E., Karno, M. P., Warda, U. S., Niv, N., & Moore, A. A. (2009). 
Gender and comorbidity among individuals with opioid use disorders in 
the NESARC study. Addictive Behaviors, 34, 498–504.
Harvard School of Medicine. (2005). National Comorbidity Survey (NCS) 
and National Comorbidity Survey Replication (NCS-R). Retrieved from 
http://www.hcp.med.harvard.edu/ncs/index.php
Huang, B., Dawson, D. A., Stinson, F. S., Hasin, D. S., Ruan, W. J., Saha, T. 
D., . . . Grant, B. F. (2006). Prevalence, correlates, and comorbidity of 
nonmedical prescription drug use and drug use disorders in the United 
States: Results of the National Epidemiologic Survey on Alcohol and 
Related Conditions. Journal of Clinical Psychiatry, 67, 1062–1073.
Ilgen, M. A., Zivin, K., Austin, K. L., Bohnert, A. S. B., Czyz, E. K., Va-
lenstein, M., & Kilbourne, A. M. (2010). Severe pain predicts greater 
likelihood of subsequent suicide. Suicide and Life-Threatening Behavior, 
40, 597–608.
Khantzian, E. J. (1985). The self-medication hypothesis of addictive dis-
orders: Focus on heroin and cocaine dependence. American Journal of 
Psychiatry, 142, 1259–1264.
Koch, G. G., Freeman, D. H., & Freeman, J. L. (1975). Strategies in the 
multivariate analysis of data from complex surveys. International Sta-
tistical Review, 43, 59–78.
Maloney, E., Degenhardt, L., Darke, S., Mattick, R. P., & Nelson, E. C. 
(2007). Suicidal behaviour and associated risk factors among opioid-
dependent individuals: A case-control study. Addiction, 102, 1933–1941.
Martins, S. S., Fenton, M. C., Keyes, K. M., Blanco, C., Zhu, H., & Storr, 
C. L. (2011). Mood and anxiety disorders and their association with 
non-medical prescription opioid use and prescription opioid-use dis-
order: Longitudinal evidence from the National Epidemiologic Study 
on Alcohol and Related Conditions. Psychological Medicine, 1–12. 
Advance online publication. Retrieved from http://journals.cambridge.
org/action/displayAbstract?fromPage=online&aid=8407611.
Martins, S. S., Keyes, K. M., Storr, C. L., Zhu, H., & Chilcoat, H. D. 
(2009a). Pathways between nonmedical opioid use/dependence and 
psychiatric disorders: results from the National Epidemiologic Survey 
on Alcohol and Related Conditions. Drug and Alcohol Dependence, 
103, 16–24.
Martins, S. S., Storr, C. L., Zhu, H., & Chilcoat, H. D. (2009b). Correlates 
of extramedical use of OxyContin versus other analgesic opioids among 
the US general population. Drug and Alcohol Dependence, 99, 58–67.
Rao, J. N. K., & Scott, A. J. (1984). On chi-squared tests for multiway 
contingency tables with cell proportions estimated from survey data. 
Annals of Statistics, 12, 46–60.
Roy, A. (2001). Characteristics of cocaine-dependent patients who attempt 
suicide. American Journal of Psychiatry, 158, 1215–1219.
Schepis, T. S., & Hakes, J. K. (2011) Non-medical prescription use increases 
the risk for the onset and recurrence of psychopathology: Results from 
the National Epidemiological Survey on Alcohol and Related Condi-
tions. Addiction, 106, 2146–2155.
Sigmon, S. C. (2006). Characterizing the emerging population of prescrip-
tion opioid abusers. The American Journal on Addictions, 15, 208–212.
Substance Abuse and Mental Health Services Administration (Offi ce of Ap-
plied Studies). (2010a). 2009 National Survey on Drug Use and Health: 
Public Use File Codebook (Contract No. 283–2004–00022, Project No. 
9009, Deliverable 26). Research Triangle Park, NC: RTI International. 
Retrieved from www.icpsr.umich.edu.
Substance Abuse and Mental Health Services Administration, Center for 
Behavioral Health Statistics and Quality. (2010b). The DAWN Report: 
Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings 
on Drug-Related Emergency Department Visits. Rockville, MD: Author.
Substance Abuse and Mental Health Services Administration (Offi ce of 
Applied Studies). (2010c). National Survey on Drug Use and Health, 
2009 [Computer fi le]. ICPSR29621-v1. Ann Arbor, MI: Inter-university 
Consortium for Political and Social Research [distributor], 2010-11-16. 
doi:10.3886/ICPSR29621.v1
Tang, N. K. Y., & Crane, C. (2006). Suicidality in chronic pain: a review 
of the prevalence, risk factors and psychological links. Psychological 
Medicine, 36, 575–586.
Tetrault, J. M., Desai, R. A., Becker, W. C., Fiellin, D. A., Concato, J., & 
Sullivan, L. E. (2007). Gender and non-medical use of prescription 
opioids: Results from a national US survey. Addiction, 103, 258–268.
Turner, C. F., Ku, L., Rogers, S. M., Lindberg, L. D., Pleck, J. H., & Sonen-
stein, F. L. (1998). Adolescent sexual behavior, drug use, and violence: 
Increased reporting with computer survey technology. Science, 280, 
867–873.
Wilcox, H. C., Conner, K. R., & Caine, E. D. (2004). Association of alcohol 
and drug use disorders and completed suicide: An empirical review 
of cohort studies. Drug and Alcohol Dependence, 76, Supplement, 
S11–S19.
Zacny, J., Bigelow, G., Compton, P., Foley, K., Iguchi, M., & Sannerud, C. 
(2003). College on Problems of Drug Dependence taskforce on prescrip-
tion opioid non-medical use and abuse: Position statement. Drug and 
Alcohol Dependence, 69, 215–232.
